product image
The Business Cocktail

Jun 16, 2020

Biohaven buys PRV from GW Pharmaceuticals for USD 105 million GW Pharmaceuticals has announced its decision to sell its rare pediatric disease priority review voucher (PRV)...

Read More
product image
Anticoagulants (VTE & AF) Therapeutics Market

Jun 25, 2020

The Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 2020 growing at a CAGR of 8.59% from 2015 ...

Read More
product image
Global atrial fibrillation market is expected to grow to $12.5 billion by 2020

Jul 3, 2020

Global AF market was $7.2 billion in 2015 and expected to grow to $12.5 billion by 2020 with and compound annual growth rate (CAGR) of 11.62%. There are four NOACs which ar...

Read More
product image
Global VTE market is expected to grow to $4.75 billion by 2020

Jul 3, 2020

Venous Thromboembolism- Market Insights & Drugs Sales Forecast (VTE) -2020: New Report by DelveInsight suggests that the Global VTE market was $4.2 billion in 2015 and ...

Read More
product image
Anticoagulants-Market Insights; Drugs Sales Forecast (VTE & AF)

Jun 25, 2020

According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 202...

Read More
product image
A Glimpse of the Anticoagulants Therapy Market; Major Players

Jun 26, 2020

VTE therapeutics & Atrial Fibrillation market was worth USD 4 billion in 2014 and USD 7.86 billion respectively. The VTE therapeutic market is expected to reach US...

Read More
product image
Anticoagulants Market A Big Boom

Jun 25, 2020

Analyze Anticoagulants Market with DelveInsight Anticoagulants are drugs that are given to prevent blood from clotting or prevent existing clots from getting larger. They c...

Read More